Donation

The Role of Cement Augmentation with Percutaneous Vertebroplasty and Balloon Kyphoplasty for Treatment of Vertebral Compression Fractures in Multiple Myeloma: A Consensus Statement from the International Myeloma Working Group

Multiple myeloma (MM) patients often experience bone involvement, leading to painful vertebral compression fractures (VCFs) and deformities. ​ Balloon kyphoplasty (BKP) and percutaneous vertebroplasty (PV) are minimally invasive procedures that can relieve pain and restore function in MM patients with VCFs. ​ Indications for cement augmentation include persistent significant pain, significant change in disability, and acute patient-delayed for medical reasons. ​ Cement augmentation should be performed within 4-8 weeks of VCFs. ​ The maximum number of levels that should be augmented at a time is 3, and caution should be taken when treating more levels to avoid complications such as cement embolus to the lungs. ​ BKP is better than PV or non-surgical management in reducing disability, pain, and subsequent fracture risk in MM patients with VCFs. ​ Radiotherapy should be used judiciously and sparingly. ​ Bisphosphonate therapy can help stabilize bone density and provide an external scaffold of bone that stabilizes the vertebral bodies in MM patients. ​ Cement augmentation is an effective way to stabilize the anterior and middle spinal columns without the need for metalwork fixation, reducing the risk of infection in immunocompromised patients. ​ The mechanisms of bone destruction in multiple myeloma and the risk factors for vertebral fractures are discussed. ​ Vertebral fractures impact quality of life and functional status, and hyperkyphosis is associated with mortality in older women. ​

Important points:

  1. MM patients experience bone involvement and VCFs. ​
  2. BKP and PV can relieve pain and restore function in MM patients with VCFs. ​
  3. Indications for cement augmentation include persistent significant pain and change in disability. ​
  4. Cement augmentation should be performed within 4-8 weeks of VCFs. ​
  5. Caution should be taken when treating more than 3 levels to avoid complications. ​
  6. BKP is better than PV or non-surgical management in reducing disability, pain, and subsequent fracture risk. ​
  7. Radiotherapy should be used judiciously and sparingly. ​
  8. Bisphosphonate therapy stabilizes bone density and provides an external scaffold of bone. ​
  9. Cement augmentation stabilizes the spinal columns without metalwork fixation. ​
  10. Mechanisms of bone destruction in multiple myeloma and risk factors for vertebral fractures are discussed. ​
  11. Vertebral fractures impact quality of life and functional status. ​
  12. Hyperkyphosis is associated with mortality in older women. ​

Authors:

Kyriakou C, Molloy S, Vrionis F, Alberico R, Bastian L, Zonder JA, Giralt S, Raje N, Kyle RA, Roodman DGD, Dimopoulos MA, Rajkumar SV, Durie BBG, Terpos E.

Citation:

Kyriakou et al. Blood Cancer Journal ( 2019) 9:27
https://doi.org/10.1038/s41408-019-0187-7

 

Give Where Most Needed